Agios Pharmaceuticals

Agios Pharmaceuticals

Agios is the pioneering leader in PK activation and dedicated to developing transformative therapies for patients living with rare diseases. In the U.S., Agios markets a first-in-class PK activator for adults with PK deficiency. Building on its scientific expertise in classical hematology and cellular metabolism, Agios is advancing a robust pipeline of investigational medicines in α- and β-thalassemia, sickle cell disease, pediatric PK deficiency, MDS-associated anemia and phenylketonuria.

Biotechnology, Pharmaceuticals, Genetic Testing